Lipocine Inc (LPCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 0 | 0 | 0 | 7,710 | 0 |
| Gross Profit | N/A | N/A | N/A | 7,710 | N/A |
| Operating Expenses | 18,382 | 20,481 | 10,684 | 3,832 | 5 |
| Operating Income | -18,382 | -20,481 | -10,684 | 3,877 | -5 |
| Other Income | 174 | 108 | 38 | 10 | 0 |
| Pre-tax Income | -18,208 | -20,373 | -10,645 | 3,888 | -5 |
| Income Tax | 0 | 0 | -55 | 1 | N/A |
| Net Income Continuous | -18,208 | -20,372 | -10,590 | 3,887 | -5 |
| Net Income | $-18,208 | $-20,372 | $-10,590 | $3,887 | $-5 |
| EPS Basic Total Ops | -18.88 | -27.21 | -24.49 | 14.46 | -0.05 |
| EPS Basic Continuous Ops | -18.80 | -27.14 | -24.46 | 14.83 | -0.05 |
| EPS Diluted Total Ops | -18.88 | -27.21 | -24.49 | 14.46 | -0.05 |
| EPS Diluted Continuous Ops | -18.80 | -27.14 | -24.46 | 14.83 | -0.05 |
| EBITDA(a) | $-18,174 | $-20,466 | $-10,662 | $3,920 | $-15 |